Authors
Dale Porter, PhD, is the vice president, head of US oncology and immuno-oncology research at Servier, a global pharmaceutical group with a long-term approach to drug discovery and oncology research and development.
Patricia Hayes, MD, is an internal medicine physician and Texas Area Medical Director for CenterWell.
Robert Pittman is senior vice president of government affairs at Modivcare, a technology-enabled health care services company that provides a platform of integrated supportive care solutions.
Jay Anders, MD, has been chief medical officer at Medicomp Systems since August of 2014.
Advertisement
Advertisement
Trending on AJMC
1
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
2
MFN Drug Agreements Could Raise Prices Worldwide
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
5


